Patents by Inventor Nicholas Hoyle

Nicholas Hoyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electrochemiluminesence assay
    Patent number: 5723342
    Abstract: Method for measuring electrochemiluminescent phenomena at low temperatures using alkali chlorides at an increased pH and/or with a reduced initial voltage and reagents and apparatus suitable for this purpose.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: March 3, 1998
    Assignee: Boehringer Mannheim GmbH
    Inventors: Ursula Giesen, Nicholas Hoyle, Volker Klemt, Gunter Muller, Ulrich Neumann
  • Electrochemiluminescence assay
    Patent number: 5677192
    Abstract: Method for measuring electrochemiluminescent phenomena using certain detergents and, if necessary, alkali chlorides and reagents suitable for this purpose.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: October 14, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Volker Klemt, Gunter Muller, Ulrich Neumann, Ursula Giesen, Nicholas Hoyle
  • Storable protein solution
    Patent number: 5460944
    Abstract: The present invention provides a storable POD conjugate solution, characterised by a pH value of 5.0 to 6.5, adjusted by means of an organic buffer substance with a concentration of 40 to 100 mmol/l, and 0.05 to 1.0 mol/l magnesium aspartate.
    Type: Grant
    Filed: April 21, 1993
    Date of Patent: October 24, 1995
    Assignee: Boehringer Mannheim GmbH
    Inventors: Norbert Franken, Nicholas Hoyle, Gunter Pappert
  • Method and standard solution for the determination of thyroxine (T.sub.4) or triiodothyronine (T.sub.3)
    Patent number: 5342788
    Abstract: A standard solution containing thyroxine-binding globulin (TBG) and thyroxine or triiodothyronine dissolved in a buffer solution is used for calibration in a method for the determination of thyroxine (T.sub.4) or triiodothyronine (T.sub.3) in serum, wherein both human and bovine TBG can be used.
    Type: Grant
    Filed: December 29, 1992
    Date of Patent: August 30, 1994
    Assignee: Boehringer Mannheim GmbH
    Inventors: Albert Kunst, Helmut Rehner, Peter Stegmuller, Helmut Lenz, Peter Bialk, Nicholas Hoyle